首页|耐药肺炎支原体感染患儿血清WBC、IL-6、D-D水平与临床预后相关性分析

耐药肺炎支原体感染患儿血清WBC、IL-6、D-D水平与临床预后相关性分析

扫码查看
目的:探究耐药肺炎支原体(MP)感染患儿血清白细胞(WBC)、白介素-6(IL-6)、D二聚体(D-D)水平与临床预后的相关性.方法:选取2021 年8 月—2023 年8 月某院就诊的MP感染患儿150 例,依据MP耐药情况将患儿分为耐药组(n=64)和非耐药组(n=86),比较2 组血清WBC、IL-6、D-D水平;依据预后情况将耐药组患儿分为预后良好组(n=48)和预后不良组(n=16)2 个亚组,比较2 亚组入院时、治疗3d后血清WBC、IL-6、D-D水平及危重病例评分(PCIS).Pearson分析血清WBC、IL-6、D-D水平与PCIS评分的相关性,绘制ROC曲线分析血清WBC、IL-6、D-D水平对耐药MP感染患儿临床预后的诊断价值.结果:耐药组患儿血清 WBC、IL-6、D-D水平高于非耐药组,差异有统计学意义(P<0.05).入院时,预后良好组血清WBC、IL-6、D-D水平低于预后不良组,PCIS评分高于预后不良组(P<0.05);治疗3d后,2 亚组患儿血清WBC、IL-6、D-D水平较入院时降低,且预后良好组低于预后不良组,PCIS评分较入院时升高,且预后良好组高于预后不良组,差异均有统计学意义(P<0.05).Pearson相关性分析显示,PCIS评分与血清WBC、IL-6、D-D水平均呈负相关(r=-0.456、-0.511、-0.468,P均<0.001).ROC分析显示,血清WBC、IL-6、D-D水平预测耐药MP感染患儿预后不良的AUC分别为 0.841、0.732、0.825,联合检测的AUC为0.935,敏感度为 93.70%,特异度为 85.40%.结论:耐药MP感染患儿血清WBC、IL-6、D-D水平呈现高表达,且与不良预后存在关联,三者联合检测有助于预测耐药MP感染患儿的预后,指导临床诊疗.
Correlation analysis between serum WBC,IL-6,D-D levels and clinical prognosis in children with drug-resistant Mycoplasma pneumoniae infection
Objective:To investigate the correlation between white blood cell(WBC),interleukin-6(IL-6),and D-dimer(D-D)levels and clinical prognosis in children with drug-resistant Mycoplasma pneumoniae(MP).Methods:150 MP-infected children who visited a hospital from August 2021 to August 2023 were selected,and throat swabs were collected for MP culture and drug sensitivity testing.The children were divided into a drug-resistant group(n=64)and a non-drug-resistant group(n=86)based on MP resist-ance,and serum WBC,IL-6,and D-D levels were compared between the two groups.The children in the drug-resistant group were re-divided into two groups according to their prognosis,and the serum WBC,IL-6,D-D levels and paediatric critical illness score(PCIS)were compared between the two groups at the time of admission and 3 days after the treatment.The correlation between levels of serum WBC,IL-6,D-D and PCIS scores was analyzed by Pearson's analysis.ROC curves were plotted to analyze the influence of the serum WBC,IL-6 and D-D levels on the prognosis of the patients with drug-resistant MP infection.Results:The WBC,IL-6 and D-D levels of the children in the drug-resistant group were higher than those in the non-drug-resistant group(P<0.05).At admission,the levels of WBC,IL-6,and D-D of the children in the good prognosis group were lower than those in the poor prognosis group,and their PCIS scores were higher than those in the poor prognosis group(P<0.05).3 days after the treatment,the levels of WBC,IL-6,and D-D of both groups of children decreased compared with those at admission,while the PCIS scores increased(P<0.05).In addition,the WBC,IL-6,and D-D levels of children in the good prognosis group were lower than those in the poor prognosis group,and their PCIS scores were higher than those in the poor prognosis group(P<0.05).Pearson correlation analysis showed that the PCIS score was nega-tively correlated with serum WBC,IL-6,and D-D levels(r=-0.456,-0.511,-0.468,all P<0.001).The AUCs of WBC,IL-6 and D-D for diagnosing poor prognosis of children with drug-resistant MP infection were 0.841,0.732 and 0.825,and the AUC of the combination of the three diagnoses was0.935,with a sensitivity and specificity of 93.70%and85.40%,respectively.Conclusion:WBC,IL-6 and D-D levels show high expression in children with drug-resistant MP infection,and there is an association with poor prog-nosis,and the combined detection of the three could help to predict the prognosis of children with drug-resistant MP infection and guide the clinical diagnosis and treatment.

PneumoniaMycoplasma infectionDrug-resistant,macrolidesLeukocytesInterleukin-6D-dimerPrognosis

丁增南、安静

展开 >

河南省许昌市中心医院 儿童重症监护室,461000

肺炎,支原体 耐药,大环内酯类 白细胞 白介素-6 D-二聚体 预后

许昌市科技计划项目

20190213167

2024

淮海医药
蚌埠市医学科学情报站 《淮海医药》编辑部

淮海医药

影响因子:0.58
ISSN:1008-7044
年,卷(期):2024.42(5)
  • 13